Announcements Trials
Browse Landscape

Phase

Phase 1/2 5Phase 1 4Phase 2 3Phase 4 1Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Multiple Myeloma 11Neoplasms 8Vomiting 6Nausea 5Prostatic Neoplasms 2Pancreatic Neoplasms 2Pain, Postoperative 2Neoplasm, Residual 2Lymphoma 2Carcinoma, Non-Small-Cell Lung 2Burkitt Lymphoma 2Breast Neoplasms 2Wrist Fractures 1Systemic Inflammatory Response Syndrome 1Supratentorial Neoplasms 1Radicular Cyst 1Postoperative Nausea and Vomiting 1Postoperative Complications 1Peripheral Nervous System Diseases 1Ovarian Neoplasms 1Mediastinal Neoplasms 1Malnutrition 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Lymphohistiocytosis, Hemophagocytic 1

Interventions

ceftolozane, tazobactam drug combination 2Meropenem 2Itraconazole 2rasburicase 1pegylated granulocyte colony-stimulating factor 1pegaspargase 1fludarabine phosphate 1fludarabine 1eltrombopag 1drotrecogin alfa activated 1dexamethasone 21-phosphate 1Voriconazole 1Vancomycin 1Uric Acid 1Urate Oxidase 1Tropisetron 1Teicoplanin 1Solutions 1Ribavirin 1Pegloticase 1Oxidoreductases 1Ofloxacin 1Micafungin 1Metronidazole 1Imatinib Mesylate 1Hydromorphone 1Human Papillomavirus Recombinant Vaccine nonavalent 1Dexamethasone 1Dasatinib 1Ciprofloxacin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Hematologic Neoplasms × Dexamethasone × Clear all
NCT02576327 2016-12-30

A Study Evaluating the Efficacy and Safety of Aprepitant in Autologous Hematopoietic Stem Cell Transplantation

Peking University

Phase 4 Unknown
130 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, Vomiting, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡